METHODS USED TO MEASURE PATIENT PREFERENCES IN PSORIASIS TREATMENTS - AN OVERVIEW WITH REGARDS TO THE GERMAN IQWIG AND G-BA

被引：0

作者：

Gutknecht, M. ^{[1
]}

Herrlein, O. ^{[1
]}

Augustin, M. ^{[1
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

来源：

VALUE IN HEALTH | 2014年 / 17卷 / 07期

关键词：

D O I：

10.1016/j.jval.2014.08.1930

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PRM177

引用

页码：A574 / A574

页数：1

共 7 条

[1] Methods used to measure patient preferences in psoriasis treatments and recommendations of the German IQWiG
Gutknecht, M.
Herrlein, O.
Augustin, M.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E162 - E163
[2] A COMPARISON OF GERMAN BENEFIT ASSESSMENTS BY G-BA, IQWIG AND MANUFACTURERS
Eheberg, D.
Lebioda, A.
Huelsebeck, M.
Plantoer, S.
[J]. VALUE IN HEALTH, 2013, 16 (07) : A484 - A484
[3] News of G-BA and IQWiG Current Methods of the early Benefit Assessment
Lietz, Christine
Wilken, Matthias
[J]. PHARMAZEUTISCHE INDUSTRIE, 2013, 75 (04): : 582 - 588
[4] A systematic review on methods used to evaluate patient preferences in psoriasis treatments
Gutknecht, M.
Schaarschmidt, M. -L.
Herrlein, O.
Augustin, M.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (09) : 1454 - 1464
[5] DID IQWIG'S DRUG APPRAISALS IN CONNECTION WITH G-BA'S DIRECTIVES CHANGE PRESCRIBING BEHAVIOR OF GERMAN PHYSICIANS?
Valentin, M.
Neises, G.
Salek, S.
[J]. VALUE IN HEALTH, 2011, 14 (07) : A351 - A351
[6] DIFFERENCES AND DECISION DRIVERS IN THE HTA-OUTCOME CATEGORY LOWER BENEFIT BETWEEN IQWIG AND G-BA ASSMENT IN THE GERMAN AMNOG PROCESS
von Hein, M.
Jakovac, M.
Peters, A.
Eheberg, D.
[J]. VALUE IN HEALTH, 2017, 20 (09) : A664 - A664
[7] INFLUENCING FACTORS FOR A RENEWED BENEFIT ASSESSMENT IN THE GERMAN HTA PROCESS - A COMPARATIVE OVERVIEW OF 13 AND 14 IN CHAPTER 5 OF THE G-BA RULES OF PROCEDURE
Bonduelle, D.
Fischer, T.
Schwarz, S.
Lukas, M.
[J]. VALUE IN HEALTH, 2019, 22 : S610 - S610

← 1 →